发明授权
US07816382B2 Linear urea mimics antagonists of P2Y1 receptor useful in the treatment of thrombotic condition
有权
线性尿素模拟P2Y1受体拮抗剂可用于治疗血栓形成
- 专利标题： Linear urea mimics antagonists of P2Y1 receptor useful in the treatment of thrombotic condition
- 专利标题（中）： 线性尿素模拟P2Y1受体拮抗剂可用于治疗血栓形成
-
申请号： US11474900申请日： 2006-06-26
-
公开(公告)号： US07816382B2公开(公告)日： 2010-10-19
- 发明人: Hannguang J. Chao , R. Michael Lawrence , Rejean Ruel , James C. Sutton
- 申请人： Hannguang J. Chao , R. Michael Lawrence , Rejean Ruel , James C. Sutton
- 申请人地址： US NJ Princeton
- 专利权人： Bristol-Myers Squibb Company
- 当前专利权人： Bristol-Myers Squibb Company
- 当前专利权人地址： US NJ Princeton
- 代理商 Jing G. Sun
- 主分类号： A61K31/44
- IPC分类号： A61K31/44 ; C07D213/643 ; C07D213/75
摘要：
The present invention provides novel urea mimics and analogues of Formula (I): or a stereoisomer, tautomer, pharmaceutically acceptable salt or solvate form thereof, wherein the variables A, B, W, and R6 are as defined herein. These compounds are selective inhibitors of the human P2Y1 receptor which can be used as medicaments.
公开/授权文献
信息查询
